49 babies die during clinical trials at All India Institute of Medical Sciences

Alternative News, Information, and Analysis
Rogue Government
What Really Happened
Citizens for Legit Gov.
Raw Story
Info Wars
Information Clearing House
American Free Press
Cremation of Care
The Peoples Voice
Free Market News
Uncover The News
Think Progress
Media Monarchy
Information Liberation
News Hounds
Global Research
Cryptogon
The Daily Reckoning
Narco News
Media Matters
Truth News
Uruknet
Common Dreams
Alternet
Antiwar
Aftermath News
Steve Quayle
Parallel Normal
Wayne Madsen
Rebel News
Etherzone
Online Journal
Lew Rockwell
Dissident Voice
News With Views
Jeff Rense
Winter Patriot
Strike The Root
Old Thinker
Greg Nixon
CNS News
IntelliBreifs
Electric Politics
Stop The Lie
Barry Lando
Amy de Miceli
Crooks and Liars
Rumor Mill News
Daily Newscaster
Aangirfan
OpEDNews
The Brad Blog
Counter Punch
Buzzflash
America Blog
Tom Flocco
Shadow Monkey

NewsWires
News Now
My Way News
Reuters Alert Net
1st Headlines
Yahoo News
Ananova
Excite AP
Knight Ridder
Newsday AP
Google News
Swiss Info
ABC Wire
News Interactive
US Newswire
World News Network
United Press Int.
Associated Press
Excite News
MSN News
PR Newswire
Reuters
Scripps Howard
Xinhua
ZD Net
Online Only
Natural News
VOA News
Huffington Post
World Net Daily
Drudge Report
Newsmax
Short News
Capitol Hill Blue
Business / Economics
Market Watch
Bloomberg
Wall Street Journal
RTT News
CNN Money
Forbes
Business Week
Funny Money Report
Market Oracle
Money Morning
The Street
Shadow Stats
Economist
Financial Times
Fortune Magazine
Kitco
Gold Eagle
321 Gold
Stock Charts
Milplex / Defense
Danger Room
Washington Technology
Defense Industry Daily
Global Security
Defense Link
Space War
Jane's
Defense Tech
Strategy Page
Military Info Tech
Major US Newspapers
New York Times
New York Post
New York Daily News
Washington Post
Washington Times
L.A. Times
USA Today
Science / Tech News
Wired
PHYSorg
Science Daily
PopSci
Engadget
New Scientist
Popular Science
Science Magazine
Science News
SlashDot
Scientific American
Spectrum IEEE
Technology Review
ZD Net
Technology News
The Register
Tech News World
VNU Net
Satire & Animation
Onion YouTube
Wahoos Mopar Grave Yard
Royal Canadian Air Farce
The Daily Show
The Colbert Report
Mark Fiore
All Hat No Cattle
Mack White
Jim Siergey
This Modern World
Propaganda Remix Project
Too Stupid To Be President
Internet Weekly Report
Kontraband
Holy Lemon

Health-Environment

49 babies die during clinical trials at All India Institute of Medical Sciences
Published on 19-08-2008	Email To Friend Print Version
Source: China View As many as 49 babies, many of whom had not even celebrated their first birthday, have died at the All India Institute of Medical Sciences(AIIMS) while being subjected to clinical trials for testing new drugs and therapies over the last two and a half years. Responding to a Right to Information (RTI) query on clinical trials on babies, the AIIMS administration admitted on Monday that of the 4,142 babies -- 2,728 of whom were below the age of one -- who were enrolled for clinical trials by the institute's department of pediatrics, 49 had died since Jan. 1, 2006. The department conducted 42 sets of trials on babies during this period. In its reply, AIIMS said the deaths amounted to a 1.18 percent mortality rate. The RTI query was filed by Rahul Verma of Uday Foundation for Congenital Defects and Rare Blood Groups, an NGO. Clinical trials are the final stage of research conducted to answer questions about safety and efficacy of vaccines, drugs and devices, new therapies and forms of care or new ways of using known treatments. Many of these trials are for foreign drugs. India recently became Asia's most popular destination for conducting clinical trials. According to the Planning Commission, 139 new trials were outsourced to India recently. AIIMS has said five foreign-manufactured medicines were tested during the trials. They were zinc tablets for treating zinc deficiency and serving as a nutritional supplement, olmesartan andvalsartan for treating blood pressure-related problems, rituximab for treating chronic focal encephalitis and gene-activated human glucocerebrosidase for treating Gaucher's disease, which affects the liver. Verma said, "This is shocking. We decided to file the RTI when we saw parents unable to admit their seriously ill children at AIIMS while children of some other poor and illiterate families were being kept in the hospital needlessly for a long time." He added, "AIIMS said in its reply that families of patients are given social counseling before trials are started. With most patients in AIIMS being illiterate and belonging to extremely poor families, I doubt if they even understand what a clinical trial is and what their children are being subjected to." In reply, an AIIMS official said, "All the deaths can't be attributed to the trials. Some patients were suffering from conditions in which mortality was the normal outcome and we were trying to see whether a drug could improve the situation. Some other trials didn't even use medications. They involved behavioral methods like nursing care." He added, "Trials in AIIMS are conducted under strict protocol and every step is scrutinized through faculty presentations and data safety management groups before ethical clearances are received." Asked about the socio-economic status of patients on whom clinical trials were conducted, AIIMS replied, "The children eligible for trials represent a mix of patients attending the outpatient and in-patient services. The eligibility is based on the aims of respective studies. The department provides detailed information on the inclusion and exclusion criteria to the AIIMS ethics committee and sponsors." Verma said the consent form that has to be filled by parents was read out by the treating physician for parents who were not able to read it themselves. "The question is, if the parents can’t read or write, do you really expect them to understand the implications of these trials?" Verma asked.